BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 22173241)

  • 21. Cell and molecular determinants of in vivo efficacy of the BH3 mimetic ABT-263 against pediatric acute lymphoblastic leukemia xenografts.
    Suryani S; Carol H; Chonghaile TN; Frismantas V; Sarmah C; High L; Bornhauser B; Cowley MJ; Szymanska B; Evans K; Boehm I; Tonna E; Jones L; Manesh DM; Kurmasheva RT; Billups C; Kaplan W; Letai A; Bourquin JP; Houghton PJ; Smith MA; Lock RB
    Clin Cancer Res; 2014 Sep; 20(17):4520-31. PubMed ID: 25013123
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular mechanisms of reduced nerve toxicity by titanium dioxide nanoparticles in the phoxim-exposed brain of Bombyx mori.
    Xie Y; Wang B; Li F; Ma L; Ni M; Shen W; Hong F; Li B
    PLoS One; 2014; 9(6):e101062. PubMed ID: 24971466
    [TBL] [Abstract][Full Text] [Related]  

  • 23. RNA sequencing: from tag-based profiling to resolving complete transcript structure.
    de Klerk E; den Dunnen JT; 't Hoen PA
    Cell Mol Life Sci; 2014 Sep; 71(18):3537-51. PubMed ID: 24827995
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epigenetic deregulation in pediatric acute lymphoblastic leukemia.
    Chatterton Z; Morenos L; Mechinaud F; Ashley DM; Craig JM; Sexton-Oates A; Halemba MS; Parkinson-Bates M; Ng J; Morrison D; Carroll WL; Saffery R; Wong NC
    Epigenetics; 2014 Mar; 9(3):459-67. PubMed ID: 24394348
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genome-scale technology driven advances to research into normal and malignant haematopoiesis.
    Göttgens B
    Scientifica (Cairo); 2012; 2012():437956. PubMed ID: 24278696
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genome-wide signatures of differential DNA methylation in pediatric acute lymphoblastic leukemia.
    Nordlund J; Bäcklin CL; Wahlberg P; Busche S; Berglund EC; Eloranta ML; Flaegstad T; Forestier E; Frost BM; Harila-Saari A; Heyman M; Jónsson OG; Larsson R; Palle J; Rönnblom L; Schmiegelow K; Sinnett D; Söderhäll S; Pastinen T; Gustafsson MG; Lönnerholm G; Syvänen AC
    Genome Biol; 2013 Sep; 14(9):r105. PubMed ID: 24063430
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular markers in ALL: Clinical implications.
    Kimura S; Mullighan CG
    Best Pract Res Clin Haematol; 2020 Sep; 33(3):101193. PubMed ID: 33038982
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New genetic abnormalities and treatment response in acute lymphoblastic leukemia.
    Meijerink JP; den Boer ML; Pieters R
    Semin Hematol; 2009 Jan; 46(1):16-23. PubMed ID: 19100364
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Digital gene expression profiling of primary acute lymphoblastic leukemia cells.
    Nordlund J; Kiialainen A; Karlberg O; Berglund EC; Göransson-Kultima H; Sønderkær M; Nielsen KL; Gustafsson MG; Behrendtz M; Forestier E; Perkkiö M; Söderhäll S; Lönnerholm G; Syvänen AC
    Leukemia; 2012 Jun; 26(6):1218-27. PubMed ID: 22173241
    [TBL] [Abstract][Full Text] [Related]  

  • 30. p53-independent epigenetic repression of the p21(WAF1) gene in T-cell acute lymphoblastic leukemia.
    Davies C; Hogarth LA; Dietrich PA; Bachmann PS; Mackenzie KL; Hall AG; Lock RB
    J Biol Chem; 2011 Oct; 286(43):37639-50. PubMed ID: 21903579
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interactions between acute lymphoblastic leukemia and bone marrow stromal cells influence response to therapy.
    Tesfai Y; Ford J; Carter KW; Firth MJ; O'Leary RA; Gottardo NG; Cole C; Kees UR
    Leuk Res; 2012 Mar; 36(3):299-306. PubMed ID: 21889797
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of new markers discriminating between myeloid and lymphoid acute leukemia.
    Haouas H; Haouas S; Uzan G; Hafsia A
    Hematology; 2010 Aug; 15(4):193-203. PubMed ID: 20670477
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long non-coding RNAs defining major subtypes of B cell precursor acute lymphoblastic leukemia.
    James AR; Schroeder MP; Neumann M; Bastian L; Eckert C; Gökbuget N; Tanchez JO; Schlee C; Isaakidis K; Schwartz S; Burmeister T; von Stackelberg A; Rieger MA; Göllner S; Horstman M; Schrappe M; Kirschner-Schwabe R; Brüggemann M; Müller-Tidow C; Serve H; Akalin A; Baldus CD
    J Hematol Oncol; 2019 Jan; 12(1):8. PubMed ID: 30642353
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of B- and T-lineage acute lymphoblastic leukemia by integrated analysis of MicroRNA and mRNA expression profiles.
    Fulci V; Colombo T; Chiaretti S; Messina M; Citarella F; Tavolaro S; Guarini A; Foà R; Macino G
    Genes Chromosomes Cancer; 2009 Dec; 48(12):1069-82. PubMed ID: 19760605
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Extensive relationship between antisense transcription and alternative splicing in the human genome.
    Morrissy AS; Griffith M; Marra MA
    Genome Res; 2011 Aug; 21(8):1203-12. PubMed ID: 21719572
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The emerging role of RNA in the regulation of gene transcription in human cells.
    Morris KV
    Semin Cell Dev Biol; 2011 Jun; 22(4):351-8. PubMed ID: 21333746
    [TBL] [Abstract][Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.